Published in Front Oncol on August 02, 2016
Key Players in Choline Metabolic Reprograming in Triple-Negative Breast Cancer. Front Oncol (2016) 0.75
Phosphatidylcholine-specific phospholipase C inhibition down- regulates CXCR4 expression and interferes with proliferation, invasion and glycolysis in glioma cells. PLoS One (2017) 0.75
Screening the active compounds of Phellodendri Amurensis cortex for treating prostate cancer by high-throughput chinmedomics. Sci Rep (2017) 0.75
Metabolic characterization and pathway analysis of berberine protects against prostate cancer. Oncotarget (2017) 0.75
Phosphatidylcholine-specific phospholipase C inhibition reduces HER2-overexpression, cell proliferation and in vivo tumor growth in a highly tumorigenic ovarian cancer model. Oncotarget (2017) 0.75
The regulation and cellular functions of phosphatidylcholine hydrolysis. Biochem J (1990) 3.44
Phosphatidylcholine breakdown and signal transduction. Biochim Biophys Acta (1994) 3.42
The therapeutic promise of the cancer stem cell concept. J Clin Invest (2010) 3.26
Phospholipases C and A2 control lysosome-mediated IL-1 beta secretion: Implications for inflammatory processes. Proc Natl Acad Sci U S A (2004) 3.05
Potential role of phospholipases in virulence and fungal pathogenesis. Clin Microbiol Rev (2000) 3.05
Choline metabolism in malignant transformation. Nat Rev Cancer (2011) 2.85
Tumour phospholipid metabolism. NMR Biomed (1999) 2.74
Bacterial phospholipases C. Microbiol Rev (1993) 2.34
Phosphatidylcholine and choline homeostasis. J Lipid Res (2008) 2.17
Alterations of choline phospholipid metabolism in ovarian tumor progression. Cancer Res (2005) 2.11
Diacylglycerol, when simplicity becomes complex. Trends Biochem Sci (2006) 1.86
Phosphocholine as a biomarker of breast cancer: molecular and biochemical studies. Int J Cancer (2007) 1.72
Identification of neutral active phospholipase C which hydrolyzes choline glycerophospholipids and plasmalogen selective phospholipase A2 in canine myocardium. J Biol Chem (1985) 1.65
Activation of phosphatidylcholine cycle enzymes in human epithelial ovarian cancer cells. Cancer Res (2010) 1.65
Phospholipase C-mediated hydrolysis of phosphatidylcholine is an important step in PDGF-stimulated DNA synthesis. Cell (1990) 1.64
Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions. J Natl Cancer Inst (2002) 1.51
Herceptin-induced inhibition of ErbB2 signaling involves reduced phosphorylation of Akt but not endocytic down-regulation of ErbB2. Int J Cancer (2005) 1.41
Lipids and lipid modifications in the regulation of membrane traffic. Curr Opin Cell Biol (2007) 1.30
Phosphatidylcholine-specific phospholipase C activation in epithelial ovarian cancer cells. Cancer Res (2008) 1.19
Inhibition of phosphatidylcholine-specific phospholipase C downregulates HER2 overexpression on plasma membrane of breast cancer cells. Breast Cancer Res (2010) 1.16
MR evaluation of response to targeted treatment in cancer cells. NMR Biomed (2011) 1.14
Involvement of phosphatidylcholine-specific phospholipase C in platelet-derived growth factor-induced activation of the mitogen-activated protein kinase pathway in Rat-1 fibroblasts. J Biol Chem (1997) 1.07
Inhibition of phosphatidylcholine-specific phospholipase C results in loss of mesenchymal traits in metastatic breast cancer cells. Breast Cancer Res (2012) 1.04
Antibodies prepared to Bacillus cereus phospholipase C crossreact with a phosphatidylcholine preferring phospholipase C in mammalian cells. Biochem Biophys Res Commun (1986) 1.02
Functional interactions between Choline kinase α, epidermal growth factor receptor and c-Src in breast cancer cell proliferation. Oncogene (2011) 1.02
Phosphatidylcholine-specific phospholipase C in mitogen-stimulated fibroblasts. Exp Cell Res (2004) 1.01
Phosphatidylcholine-specific phospholipase C (PC-PLC) is required for LPS-mediated macrophage activation through CD14. J Leukoc Biol (2006) 1.00
In vivo proton MR spectroscopy of the breast using the total choline peak integral as a marker of malignancy. AJR Am J Roentgenol (2009) 1.00
NIH 3T3 cells stably transfected with the gene encoding phosphatidylcholine-hydrolyzing phospholipase C from Bacillus cereus acquire a transformed phenotype. Mol Cell Biol (1994) 0.99
Phospholipase D1 and choline kinase-α are interactive targets in breast cancer. Cancer Biol Ther (2014) 0.98
Detection of phosphatidylcholine-specific phospholipase C in NIH-3T3 fibroblasts and their H-ras transformants: NMR and immunochemical studies. Anticancer Res (1996) 0.98
Cellular localization and functional role of phosphatidylcholine-specific phospholipase C in NK cells. J Immunol (2001) 0.96
Functional role of phosphatidylcholine-specific phospholipase C in regulating CD16 membrane expression in natural killer cells. Eur J Immunol (2007) 0.95
Evidence for involvement of phosphatidylcholine-phospholipase C and protein kinase C in transforming growth factor-beta signaling. J Biol Chem (1995) 0.92
Choline Kinase Alpha as an Androgen Receptor Chaperone and Prostate Cancer Therapeutic Target. J Natl Cancer Inst (2015) 0.92
In vivo detection of phospholipase C by enzyme-activated near-infrared probes. Bioconjug Chem (2011) 0.92
Expression and role of phosphatidylcholine-specific phospholipase C in human NK and T lymphocyte subsets. Eur J Immunol (2006) 0.89
Changes of phosphatidylcholine-specific phospholipase C in hepatocarcinogenesis and in the proliferation and differentiation of rat liver cancer cells. Cell Biol Int (1997) 0.88
Characterisation of in vivo ovarian cancer models by quantitative 1H magnetic resonance spectroscopy and diffusion-weighted imaging. NMR Biomed (2011) 0.88
The plant non-specific phospholipase C gene family. Novel competitors in lipid signalling. Prog Lipid Res (2012) 0.88
Elucidation of the Roles of Tumor Integrin β1 in the Extravasation Stage of the Metastasis Cascade. Cancer Res (2016) 0.87
Cooperation of phosphatidylcholine-specific phospholipase C and basic fibroblast growth factor in the neural differentiation of mesenchymal stem cells in vitro. Int J Biochem Cell Biol (2007) 0.87
CD38 signaling regulates B lymphocyte activation via a phospholipase C (PLC)-gamma 2-independent, protein kinase C, phosphatidylcholine-PLC, and phospholipase D-dependent signaling cascade. J Immunol (2005) 0.87
Adaptive functional differentiation of dendritic cells: integrating the network of extra- and intracellular signals. Blood (2006) 0.87
Selective localization of phosphatidylcholine-derived signaling in detergent-resistant membranes from synaptic endings. Biochim Biophys Acta (2009) 0.86
Monitoring response to cytostatic cisplatin in a HER2(+) ovary cancer model by MRI and in vitro and in vivo MR spectroscopy. Br J Cancer (2013) 0.85
Involvement of phosphatidylcholine-selective phospholipase C in activation of mitogen-activated protein kinase pathways in imidazoline receptor antisera-selected protein. J Cell Biochem (2006) 0.85
Global metabolic profile identifies choline kinase alpha as a key regulator of glutathione-dependent antioxidant cell defense in ovarian carcinoma. Oncotarget (2015) 0.83
Contrasting effects of phosphatidylinositol- and phosphatidylcholine-specific phospholipase C on apoptosis in cultured endothelial cells. Endothelium (2006) 0.83
In vivo detection of choline in ovarian tumors using 3D magnetic resonance spectroscopy. Invest Radiol (2011) 0.82
Cell-cycle-dependent PC-PLC regulation by APC/C(Cdc20)-mediated ubiquitin-proteasome pathway. J Cell Biochem (2009) 0.81
Phosphatidylcholine-specific phospholipase C and ROS were involved in chicken blastodisc differentiation to vascular endothelial cells. J Cell Biochem (2007) 0.81
Magnetic resonance spectroscopy for detection of choline kinase inhibition in the treatment of brain tumors. Mol Cancer Ther (2015) 0.81
Isolation and properties of a phosphatidylcholine-specific phospholipase C from bull seminal plasma. J Biol Chem (1986) 0.80
Correlation of Calcium-independent Phosphatidylcholine-specific Phospholipase C with gamma-GT in Hepatoma Cells. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) (1998) 0.80
PKC alpha depletion in RAW264.7 macrophages following microbial/IFNgamma stimulation is PC-PLC-mediated. Antioxid Redox Signal (2005) 0.79
Detection of neutral active phosphatidylcholine-specific phospholipase C in Friend leukemia cells before and after erythroid differentiation. Anticancer Res (1994) 0.78
Inhibition of Phosphatidylcholine-Specific Phospholipase C Interferes with Proliferation and Survival of Tumor Initiating Cells in Squamous Cell Carcinoma. PLoS One (2015) 0.78
Activation of phosphatidylcholine signalling during oxidative stress in synaptic endings. Neurochem Int (2008) 0.78
Phosphatidylcholine-specific phospholipase inhibitor D609 differentially affects MAP kinases and immediate-early genes in PC12 cells. Cell Signal (1998) 0.76
In vivo Magnetic Resonance Metabolic and Morphofunctional Fingerprints in Experimental Models of Human Ovarian Cancer. Front Oncol (2016) 0.76
What Is the True Structure of D609, a Widely Used Lipid Related Enzyme Inhibitor? Org Lett (2016) 0.76